CJJD [CHINA JO-JO DRUGSTORES] 10-K: (Original Filing)

[FORM 10-K þ For the fiscal year ended March 31, 2013 or o For the transition period from _______________________ to ___________________ 001-34711 CHINA JO-JO DRUGSTORES, INC . (Exact name of issuer as specified in its charter) Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District,] [List of Subsidiaries 1. Renovation Investment (Hong Kong) Co., Ltd. (“Renovation”) is a Hong Kong company and is wholly-owned by the Company. 2. Hangzhou Jiutong Medical Technology Co., Ltd. is a Chinese company and is wholly-owned by Renovation. 3. Zhejiang Shouantang Pharmaceutical Technology Co., Ltd. (“Shouantang Technology”) is a Chinese company and is wholly-owned by Renovation. 4. Zhejiang Jiuxin Investment] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-171849) of China Jo-Jo Drugstores, Inc. and subsidiaries of our report dated July 1, 2013 relating to the consolidated financial statements, which appear in this Form 10-K. New York, New York July 1, 2013 EX-23 3] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lei Liu, certify that: I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ming Zhao, certify that: I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Lei Liu Lei Liu Chief Executive Officer July 1, 2013 EX-32.1 6 f10k2013ex32i_chinajojo.htm SECTION 906 CERTIFICATION BY] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Ming Zhao Ming Zhao Chief Financial Officer July 1, 2013 EX-32.2 7 f10k2013ex32ii_chinajojo.htm SECTION 906 CERTIFICATION BY]

CJJD [CHINA JO-JO DRUGSTORES] 10-K: FORM 10-K þ For the fiscal year ended

[FORM 10-K þ For the fiscal year ended March 31, 2013 or o For the transition period from _______________________ to ___________________ 001-34711 CHINA JO-JO DRUGSTORES, INC . (Exact name of issuer as specified in its charter) Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District,] [List of Subsidiaries 1. Renovation Investment (Hong Kong) Co., Ltd. (“Renovation”) is a Hong Kong company and is wholly-owned by the Company. 2. Hangzhou Jiutong Medical Technology Co., Ltd. is a Chinese company and is wholly-owned by Renovation. 3. Zhejiang Shouantang Pharmaceutical Technology Co., Ltd. (“Shouantang Technology”) is a Chinese company and is wholly-owned by Renovation. 4. Zhejiang Jiuxin Investment] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-171849) of China Jo-Jo Drugstores, Inc. and subsidiaries of our report dated July 1, 2013 relating to the consolidated financial statements, which appear in this Form 10-K. New York, New York July 1, 2013 EX-23 3] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lei Liu, certify that: I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ming Zhao, certify that: I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Lei Liu Lei Liu Chief Executive Officer July 1, 2013 EX-32.1 6 f10k2013ex32i_chinajojo.htm SECTION 906 CERTIFICATION BY] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Ming Zhao Ming Zhao Chief Financial Officer July 1, 2013 EX-32.2 7 f10k2013ex32ii_chinajojo.htm SECTION 906 CERTIFICATION BY]

CMGE [China Mobile Games & Entertainment] 6-K: (Original Filing)

[CMGE Announces Changes to Board of Directors GUANGZHOU, China, July 1, 2013 — China Mobile Games and Entertainment Group Limited (“CMGE” or the “Company”) (NASDAQ: CMGE), a leading mobile game company in China, today announced that Mr. Haila Wang, an independent director, has resigned from the Company’s board of directors, effective July 1, 2013. The Company also announced that Mr.] [China Mobile Games and Entertainment Group Limited Description]

By | 2016-03-18T02:03:03+00:00 July 1st, 2013|Categories: Chinese Stocks, CMGE, SEC Original|Tags: , , , , , |0 Comments

CYD [CHINA YUCHAI INTERNATIONAL] 6-K: (Original Filing)

[NOTICE OF ANNUAL GENERAL MEETING STYLE="font-family:Times New Roman" SIZE="2"> CHINA YUCHAI INTERNATIONAL LIMITED Tol Shareholders Meeting CHINA YUCHAI INTERNATIONAL LIMITEDmpany NOTICE IS HEREBY GIVEN that the Annual General Meeting (the Ordinary Business 1. To receive andopt the audited financial statements and independent auditors report for the financial year ended December31, 2012.] [EX-99.2 d561098dex992.htm 3 EX-99.2]

By | 2016-02-07T07:49:17+00:00 July 1st, 2013|Categories: Chinese Stocks, CYD, SEC Original|Tags: , , , , , |0 Comments

CMGE [China Mobile Games & Entertainment] 6-K: CMGE Announces Changes to Board of Directors GUANGZHOU,

[CMGE Announces Changes to Board of Directors GUANGZHOU, China, July 1, 2013 — China Mobile Games and Entertainment Group Limited (“CMGE” or the “Company”) (NASDAQ: CMGE), a leading mobile game company in China, today announced that Mr. Haila Wang, an independent director, has resigned from the Company’s board of directors, effective July 1, 2013. The Company also announced that Mr.] [China Mobile Games and Entertainment Group Limited Description]

By | 2016-03-18T02:03:58+00:00 July 1st, 2013|Categories: Chinese Stocks, CMGE, Webplus ver|Tags: , , , , , |0 Comments

CYD [CHINA YUCHAI INTERNATIONAL] 6-K: NOTICE OF ANNUAL GENERAL MEETING STYLE=”font-family:Times New Roman”

[NOTICE OF ANNUAL GENERAL MEETING STYLE="font-family:Times New Roman" SIZE="2"> CHINA YUCHAI INTERNATIONAL LIMITED Tol Shareholders Meeting CHINA YUCHAI INTERNATIONAL LIMITEDmpany NOTICE IS HEREBY GIVEN that the Annual General Meeting (the Ordinary Business 1. To receive andopt the audited financial statements and independent auditors report for the financial year ended December31, 2012.] [EX-99.2 d561098dex992.htm 3 EX-99.2]

By | 2016-02-07T07:50:10+00:00 July 1st, 2013|Categories: Chinese Stocks, CYD, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] POS AM: (Original Filing)

[Post Effective Amendment No.5 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 20-4857782 (I.R.S. Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 Renmin Road South, Chengdu, P. R. China, 610041 +0086-28-86154737 Dr. Guoqing Jiang, Chief Executive Officer Tianyin Pharmaceutical Co.,] [HUNTER TAUBMAN WEISS LLP 130 w. 42nd Street, Suite 1050 New York, New York 10036 (212) 732-7184 Fax: (212) 202-6380 E-mail: LTaubman@htwlaw.com July 1, 2013 Tianyin Pharmaceutical Co., Inc. 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 Ladies and Gentlemen: Sincerely, HUNTER TAUBMAN WEISS LLP Louis E. Taubman EX-5.1 2 posam2013a5ex5i_tianyin.htm] [Patrizio & Zhao, LLC Certified Public Accountants and Consultants 322 Route 46 West Parsippany, NJ 07054 Fax: (973) 882-0788 www.pzcpa.com Member of Alliance of worldwide accounting firms CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in the Post-Effective Amendment No. 5 to a Registration Statement on Form S-1 pertaining to the registration of 12,559,099 shares of]

By | 2016-03-27T18:18:39+00:00 July 1st, 2013|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

CNET [ChinaNet Onlines,] 8-K: (Original Filing)

[Item 5.07. Submission of Matters to a Vote of Security Holders. ChinaNet Onlines, a Nevadarporation (ChinaNet), held its annual meeting of stockholders on June 28, 2013, at 2:00 p.m. local time (the Annual Meeting).There were 22,186,540 shares ofmmon stock entitled to be voted, and angregate of 13,522,282 shares present in person or by proxy at]

By | 2016-02-08T10:10:51+00:00 July 1st, 2013|Categories: Chinese Stocks, CNET, SEC Original|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] POS AM: Post Effective Amendment No.5 to FORM S-1 REGISTRATION

[Post Effective Amendment No.5 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 20-4857782 (I.R.S. Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 Renmin Road South, Chengdu, P. R. China, 610041 +0086-28-86154737 Dr. Guoqing Jiang, Chief Executive Officer Tianyin Pharmaceutical Co.,] [HUNTER TAUBMAN WEISS LLP 130 w. 42nd Street, Suite 1050 New York, New York 10036 (212) 732-7184 Fax: (212) 202-6380 E-mail: LTaubman@htwlaw.com July 1, 2013 Tianyin Pharmaceutical Co., Inc. 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 Ladies and Gentlemen: Sincerely, HUNTER TAUBMAN WEISS LLP Louis E. Taubman EX-5.1 2 posam2013a5ex5i_tianyin.htm] [Patrizio & Zhao, LLC Certified Public Accountants and Consultants 322 Route 46 West Parsippany, NJ 07054 Fax: (973) 882-0788 www.pzcpa.com Member of Alliance of worldwide accounting firms CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in the Post-Effective Amendment No. 5 to a Registration Statement on Form S-1 pertaining to the registration of 12,559,099 shares of]

By | 2016-03-27T18:19:41+00:00 July 1st, 2013|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar